Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Pharma
Merck KGaA's CDMO sales down 17%, company projects turnaround
Amid largely positive news for Merck KGaA, the company reported a 17% decline in sales for its CDMO unit, blaming destocking.
Kevin Dunleavy
May 15, 2024 11:18am
Merck KGaA, Huma roll out bladder cancer patient support app
Apr 29, 2024 11:55am
Merck KGaA earmarks €300M for an advanced research center
Apr 29, 2024 10:15am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Merck KGaA turns to storytelling for schistosomiasis awareness
Apr 2, 2024 11:37am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am